Yuan Hou

4.9k total citations · 1 hit paper
33 papers, 2.4k citations indexed

About

Yuan Hou is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Computational Theory and Mathematics. According to data from OpenAlex, Yuan Hou has authored 33 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Cardiology and Cardiovascular Medicine and 7 papers in Computational Theory and Mathematics. Recurrent topics in Yuan Hou's work include Computational Drug Discovery Methods (7 papers), Bioinformatics and Genomic Networks (6 papers) and COVID-19 Clinical Research Studies (5 papers). Yuan Hou is often cited by papers focused on Computational Drug Discovery Methods (7 papers), Bioinformatics and Genomic Networks (6 papers) and COVID-19 Clinical Research Studies (5 papers). Yuan Hou collaborates with scholars based in United States, China and Israel. Yuan Hou's co-authors include Feixiong Cheng, Yadi Zhou, Jiayu Shen, Yin Huang, William R. Martin, Andrew A. Pieper, Lang Li, Charis Eng, Jiansong Fang and Xiangxiang Zeng and has published in prestigious journals such as Nature Communications, Bioinformatics and Scientific Reports.

In The Last Decade

Yuan Hou

30 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2

2020 1.1k citations Yadi Zhou, Yuan Hou et al. Cell Discovery profile →

Peers

Countries citing papers authored by Yuan Hou

Since Specialization

Citations

This map shows the geographic impact of Yuan Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuan Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuan Hou more than expected).

Fields of papers citing papers by Yuan Hou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuan Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuan Hou. The network helps show where Yuan Hou may publish in the future.

Co-authorship network of co-authors of Yuan Hou

This figure shows the co-authorship network connecting the top 25 collaborators of Yuan Hou. A scholar is included among the top collaborators of Yuan Hou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuan Hou. Yuan Hou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Efficacy and safety of passive immunotherapies targeting amyloid beta in Alzheimer’s disease: A systematic review and meta-analysis 2025 ·PLoS Medicine ·(unknown), Yuan Hou, Bo Hu, (unknown), Andrew A. Pieper, Babak Tousi, James B. Leverenz, Feixiong Cheng	4
2	A Deep Learning-Based Structural Damage Identification Method Integrating CNN-BiLSTM-Attention for Multi-Order Frequency Data Analysis 2025 ·Buildings ·(unknown), Yuan Hou, (unknown), Junxing Zheng	4
3	A Multi-Objective Sensor Placement Method Considering Modal Identification Uncertainty and Damage Detection Sensitivity 2025 ·Buildings ·(unknown), Yuan Hou, (unknown), Junxing Zheng	3
4	Real‐world observations of GLP‐1 receptor agonists and SGLT‐2 inhibitors as potential treatments for Alzheimer's disease 2025 ·Alzheimer s & Dementia ·(unknown), Chengsheng Mao, Anna Sun, (unknown), Yuan Hou, Zhimin Fu, (unknown), James B. Leverenz, Andrew A. Pieper, Yuan Luo, (unknown), Feixiong Cheng	2
5	Discovery of plasma proteins and metabolites associated with left ventricular cardiac dysfunction in pan-cancer patients 2025 ·Cardio-Oncology ·(unknown), (unknown), Muzna Hussain, (unknown), (unknown), Yuan Hou, Mina K. Chung, Patrick Collier, Feixiong Cheng	1
6	Genome-wide DNA methylation analysis of Astragalus and Danshen on the intervention of myofibroblast activation in idiopathic pulmonary fibrosis 2023 ·BMC Pulmonary Medicine ·(unknown), Xue Liu, Guoyu Wang, Fan Wu, Yuan Hou, (unknown)	1
7	Aging‐related cell type‐specific pathophysiologic immune responses that exacerbate disease severity in aged COVID‐19 patients 2022 ·Aging Cell ·Yuan Hou, Yadi Zhou, Lara Jehi, Yuan Luo, Michaela U. Gack, Timothy A. Chan, Haiyuan Yu, Charis Eng, Andrew A. Pieper, Feixiong Cheng	10
8	Interpretable deep learning translation of GWAS and multi-omics findings to identify pathobiology and drug repurposing in Alzheimer’s disease 2022 ·Cell Reports ·Jielin Xu, Chengsheng Mao, Yuan Hou, Yuan Luo, Jessica Binder, Yadi Zhou, Lynn M. Bekris, Jiyoung Shin, Ming Hu, Fei Wang, Charis Eng, Tudor I. Oprea, Margaret E. Flanagan, Andrew A. Pieper, Jeffrey L. Cummings, James B. Leverenz, Feixiong Cheng	60
9	Cardiac risk stratification in cancer patients: A longitudinal patient–patient network analysis 2021 ·PLoS Medicine ·Yuan Hou, Yadi Zhou, Muzna Hussain, G. Thomas Budd, W.H. Wilson Tang, James Abraham, Bo Xu, Chirag Shah, Rohit Moudgil, Zoran Popović, Chris Watson, Leslie Cho, Mina K. Chung, Mohamed Kanj, Samir Kapadia, Brian P. Griffin, Lars G. Svensson, Patrick Collier, Feixiong Cheng	20
10	Multimodal single-cell/nucleus RNA sequencing data analysis uncovers molecular networks between disease-associated microglia and astrocytes with implications for drug repurposing in Alzheimer's disease 2021 ·Genome Research ·Jielin Xu, Pengyue Zhang, Yin Huang, Yadi Zhou, Yuan Hou, Lynn M. Bekris, Justin D. Lathia, Chien‐Wei Chiang, Lang Li, Andrew A. Pieper, James B. Leverenz, Jeffrey L. Cummings, Feixiong Cheng	61
11	The Epidemiological and Mechanistic Understanding of the Neurological Manifestations of COVID-19: A Comprehensive Meta-Analysis and a Network Medicine Observation 2021 ·Frontiers in Neuroscience ·Jiayu Shen, Yuan Hou, Yadi Zhou, Reena Mehra, Lara Jehi, Feixiong Cheng	2
12	Multimodal single-cell omics analysis identifies epithelium–immune cell interactions and immune vulnerability associated with sex differences in COVID-19 2021 ·Signal Transduction and Targeted Therapy ·Yuan Hou, Yadi Zhou, Michaela U. Gack, Justin D. Lathia, Asha Kallianpur, Reena Mehra, Timothy A. Chan, Jae U. Jung, Lara Jehi, Charis Eng, Feixiong Cheng	15
13	Phosphorylation of PLCγ1 by EphA2 Receptor Tyrosine Kinase Promotes Tumor Growth in Lung Cancer 2020 ·Molecular Cancer Research ·Wenqiang Song, Laura C. Kim, Wei Han, Yuan Hou, Deanna N. Edwards, Shan Wang, Timothy S. Blackwell, Feixiong Cheng, Dana M. Brantley‐Sieders, Jin Chen	9
14	Machine Learning–Based Risk Assessment for Cancer Therapy–Related Cardiac Dysfunction in 4300 Longitudinal Oncology Patients 2020 ·Journal of the American Heart Association ·Yadi Zhou, Yuan Hou, Muzna Hussain, Sherry‐Ann Brown, Thomas Budd, W.H. Wilson Tang, Jame Abraham, Bo Xu, Chirag Shah, Rohit Moudgil, Zoran Popović, Leslie Cho, Mohamed Kanj, Chris Watson, Brian P. Griffin, Mina K. Chung, Samir Kapadia, Lars G. Svensson, Patrick Collier, Feixiong Cheng	57
15	Repurpose Open Data to Discover Therapeutics for COVID-19 Using Deep Learning 2020 ·Journal of Proteome Research ·Xiangxiang Zeng, Xiang Song, Tengfei Ma, (unknown), Yadi Zhou, Yuan Hou, Zheng Zhang, Kenli Li, George Karypis, Feixiong Cheng	169
16	Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2 breakdown → 2020 ·Cell Discovery ·Yadi Zhou, Yuan Hou, Jiayu Shen, Yin Huang, William R. Martin, Feixiong Cheng	1128
17	A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19 2020 ·PLoS Biology ·Yadi Zhou, Yuan Hou, Jiayu Shen, Reena Mehra, Asha Kallianpur, Daniel A. Culver, Michaela U. Gack, Samar Farha, Joe Zein, Suzy Comhair, Claudio Fiocchi, Thaddeus S. Stappenbeck, Timothy Chan, Charis Eng, Jae U. Jung, Lara Jehi, Serpil C. Erzurum, Feixiong Cheng	132
18	A genome-wide positioning systems network algorithm for in silico drug repurposing 2019 ·Nature Communications ·Feixiong Cheng, Weiqiang Lü, Chuang Liu, Jiansong Fang, Yuan Hou, Diane E. Handy, Rui‐Sheng Wang, Yuzheng Zhao, Yi Yang, Jin Huang, David E. Hill, Marc Vidal, Charis Eng, Joseph Loscalzo	156
19	Integrative proteomics and phosphoproteomics in pulmonary arterial hypertension 2019 ·Scientific Reports ·Weiling Xu, Suzy Comhair, (unknown), Bo Hu, Yuan Hou, Yadi Zhou, Lori Mavrakis, Allison J. Janocha, Ling Li, Dongmei Zhang, Belinda Willard, Kewal Asosingh, Feixiong Cheng, Serpil C. Erzurum	54
20	Target Identification Among Known Drugs by Deep Learning from Heterogeneous Networks 2019 ·SSRN Electronic Journal ·Xiangxiang Zeng, Siyi Zhu, Weiqiang Lü, Jin Huang, Zehui Liu, Yadi Zhou, Yuan Hou, Yin Huang, Huimin Guo, Jiansong Fang, Mingyao Liu, Bruce D. Trapp, Lang Li, Ruth Nussinov, Charis Eng, Joseph Loscalzo, Feixiong Cheng	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact